136 related articles for article (PubMed ID: 28803820)
1. TITRATION: A Randomized Study to Assess 2 Treatment Algorithms with New Insulin Glargine 300 units/mL.
Yale JF; Berard L; Groleau M; Javadi P; Stewart J; Harris SB
Can J Diabetes; 2017 Oct; 41(5):478-484. PubMed ID: 28803820
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial.
Bae JH; Ahn CH; Yang YS; Moon SJ; Kwak SH; Jung HS; Park KS; Cho YM
Diabetes Metab J; 2022 Jan; 46(1):71-80. PubMed ID: 34130445
[TBL] [Abstract][Full Text] [Related]
3. Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.
Bolli GB; Riddle MC; Bergenstal RM; Wardecki M; Goyeau H; Home PD;
Diabetes Metab; 2017 Sep; 43(4):351-358. PubMed ID: 28622950
[TBL] [Abstract][Full Text] [Related]
4. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
5. Replacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Satisfaction.
Berard L; Cameron B; Woo V; Stewart J
Can J Diabetes; 2015 Aug; 39(4):296-301. PubMed ID: 25819531
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial).
Bajaj HS; Venn K; Ye C; Aronson R
Diabetes Technol Ther; 2016 Oct; 18(10):610-615. PubMed ID: 27652718
[TBL] [Abstract][Full Text] [Related]
7. Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).
Terauchi Y; Koyama M; Cheng X; Sumi M; Riddle MC; Bolli GB; Hirose T;
Diabetes Metab; 2017 Oct; 43(5):446-452. PubMed ID: 28433560
[TBL] [Abstract][Full Text] [Related]
8. Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS study.
Garg SK; Admane K; Freemantle N; Odawara M; Pan CY; Misra A; Jarek-Martynowa IR; Abbas-Raza S; Mirasol RC; Perfetti R
Endocr Pract; 2015 Feb; 21(2):143-57. PubMed ID: 25297660
[TBL] [Abstract][Full Text] [Related]
9. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
Davies M; Evans R; Storms F; Gomis R; Khunti K
Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes.
Davies M; Bain S; Charpentier G; Flacke F; Goyeau H; Woloschak M; Hasslacher C; Vespasiani G; Edelman S
J Diabetes Sci Technol; 2019 Sep; 13(5):881-889. PubMed ID: 30646755
[TBL] [Abstract][Full Text] [Related]
11. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
12. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
Davies M; Storms F; Shutler S; Bianchi-Biscay M; Gomis R;
Diabetes Care; 2005 Jun; 28(6):1282-8. PubMed ID: 15920040
[TBL] [Abstract][Full Text] [Related]
13. New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus.
Goldman J; White JR
Ann Pharmacother; 2015 Oct; 49(10):1153-61. PubMed ID: 26238470
[TBL] [Abstract][Full Text] [Related]
14. Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs.
Seufert J; Fritsche A; Pscherer S; Anderten H; Borck A; Pegelow K; Bramlage P; Pfohl M
Diabetes Obes Metab; 2019 Feb; 21(2):439-443. PubMed ID: 30226296
[TBL] [Abstract][Full Text] [Related]
15. Diabetes duration and the efficacy and safety of insulin glargine versus comparator treatment in patients with type 2 diabetes mellitus.
Garg SK; Aurand LA; Rimler MS; Dailey GE
Endocr Pract; 2014 Feb; 20(2):120-8. PubMed ID: 24013981
[TBL] [Abstract][Full Text] [Related]
16. An observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study.
Krnić M; Marolt I; Skelin M; Grulović N; Rahelić D
Diabetes Res Clin Pract; 2019 Apr; 150():144-149. PubMed ID: 30641166
[TBL] [Abstract][Full Text] [Related]
17. Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial.
Yuan L; Li F; Zhou Y; Sun R; Gao G; Zhang Q; Tang Y; Dai L; Wu J; Ma J
J Diabetes Res; 2021; 2021():5524313. PubMed ID: 34337072
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.
Aroda VR; Bain SC; Cariou B; Piletič M; Rose L; Axelsen M; Rowe E; DeVries JH
Lancet Diabetes Endocrinol; 2017 May; 5(5):355-366. PubMed ID: 28344112
[TBL] [Abstract][Full Text] [Related]
19. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
[TBL] [Abstract][Full Text] [Related]
20. The Mobile Insulin Titration Intervention (MITI) for Insulin Adjustment in an Urban, Low-Income Population: Randomized Controlled Trial.
Levy N; Moynihan V; Nilo A; Singer K; Bernik LS; Etiebet MA; Fang Y; Cho J; Natarajan S
J Med Internet Res; 2015 Jul; 17(7):e180. PubMed ID: 26187303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
